My Blog List

Wednesday, 8 November 2017

Next Generation Cancer Diagnostic Devices Sales Market Estimated to Grow Strongly by 2022

Description:

In this report, the global Next Generation Cancer Diagnostic Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Next Generation Cancer Diagnostic Devices for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India


Global Next Generation Cancer Diagnostic Devices market competition by top manufacturers/players, with Next Generation Cancer Diagnostic Devices sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Roche Holding Ltd.(Switzerland)
Abbott Laboratories(US)
Siemens Healthcare(Germany)
Agilent Technologies Inc(Germany)
Illumina Inc.(US)
Becton Dickinson and Co.(US)
QIAGEN N.V.(Germany)
Affymetrix Inc.(US)
Johnson & Johnson(US)
Thermo Fisher Scientific Inc.(US)
GE Healthcare(England)
Life Technologies Corp.(US)
Luminex Corp.(US)
Cepheid Inc.(US)
Allegro Diagnostics Corp.(Brazil)


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Next Generation Sequencing
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Next Generation Cancer Diagnostic Devices for each application, including
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1133794&req_type=disc

Table of Content:

1 Next Generation Cancer Diagnostic Devices Market Overview1.1 Product Overview and Scope of Next Generation Cancer Diagnostic Devices
1.2 Classification of Next Generation Cancer Diagnostic Devices by Product Category
1.2.1 Global Next Generation Cancer Diagnostic Devices Market Size (Sales) Comparison by Type (2012–2022)
1.2.2 Global Next Generation Cancer Diagnostic Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Next Generation Sequencing
1.2.4 qPCR & Multiplexing
1.2.5 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
1.2.6 Protein Microarrays
1.2.7 DNA Microarrays
1.3 Global Next Generation Cancer Diagnostic Devices Market by Application/End Users
1.3.1 Global Next Generation Cancer Diagnostic Devices Sales (Volume) and Market Share Comparison by Application (2012–2022)
1.3.2 Biomarker Development
1.3.3 CTC Analysis
1.3.4 Proteomic Analysis
1.3.5 Epigenetic Analysis
1.3.6 Genetic Analysis
1.4 Global Next Generation Cancer Diagnostic Devices Market by Region
1.4.1 Global Next Generation Cancer Diagnostic Devices Market Size (Value) Comparison by Region (2012–2022)
1.4.2 United States Next Generation Cancer Diagnostic Devices Status and Prospect (2012–2022)
1.4.3 China Next Generation Cancer Diagnostic Devices Status and Prospect (2012–2022)
1.4.4 Europe Next Generation Cancer Diagnostic Devices Status and Prospect (2012–2022)
1.4.5 Japan Next Generation Cancer Diagnostic Devices Status and Prospect (2012–2022)
1.4.6 Southeast Asia Next Generation Cancer Diagnostic Devices Status and Prospect (2012–2022)
1.4.7 India Next Generation Cancer Diagnostic Devices Status and Prospect (2012–2022)
1.5 Global Market Size (Value and Volume) of Next Generation Cancer Diagnostic Devices (2012–2022)
1.5.1 Global Next Generation Cancer Diagnostic Devices Sales and Growth Rate (2012–2022)
1.5.2 Global Next Generation Cancer Diagnostic Devices Revenue and Growth Rate (2012–2022)

2 Global Next Generation Cancer Diagnostic Devices Competition by Players/Suppliers, Type and Application2.1 Global Next Generation Cancer Diagnostic Devices Market Competition by Players/Suppliers
2.1.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share of Key Players/Suppliers (2012–2017)
2.1.2 Global Next Generation Cancer Diagnostic Devices Revenue and Share by Players/Suppliers (2012–2017)
2.2 Global Next Generation Cancer Diagnostic Devices (Volume and Value) by Type
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Type (2012–2017)
2.2.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Type (2012–2017)
2.3 Global Next Generation Cancer Diagnostic Devices (Volume and Value) by Region
2.3.1 Global Next Generation Cancer Diagnostic Devices Sales and Market Share by Region (2012–2017)
2.3.2 Global Next Generation Cancer Diagnostic Devices Revenue and Market Share by Region (2012–2017)
2.4 Global Next Generation Cancer Diagnostic Devices (Volume) by Application
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India